Cargando…

Cardiovascular risk profiles: A cross‐sectional study evaluating the generalizability of the glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials REWIND, LEADER and SUSTAIN‐6 to the real‐world type 2 diabetes population in the United Kingdom

AIMS: To determine the proportion of UK patients with type 2 diabetes (T2D) who meet the cardiovascular (CV) or combined CV/core eligibility criteria used for the CV outcome trials (CVOTs) of UK‐marketed glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) showing CV benefit (dulaglutide in REWIND,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webb, Joanne, Mount, Julie, von Arx, Lill‐Brith, Rachman, Jonathan, Spanopoulos, Dionysis, Wood, Robert, Tritton, Theo, Massey, Olivia, Idris, Iskandar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299650/ https://www.ncbi.nlm.nih.gov/pubmed/34668637 http://dx.doi.org/10.1111/dom.14580

Ejemplares similares

RP rewind
Publicado: (2020)

Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutide
por: Verma, Subodh, et al.
Publicado: (2021)

REWIND Diabetes for Octogenarians
por: Geberhiwot, Tarekegn
Publicado: (2021)

Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND
por: Konig, Manige, et al.
Publicado: (2021)

Treatment beliefs, health behaviors and their association with treatment outcome in type 2 diabetes
por: von Arx, Lill-Brith Wium, et al.
Publicado: (2016)

Unwinding and Rewinding: Double Faces of Helicase?
por: Wu, Yuliang
Publicado: (2012)

Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis
por: Dagenais, Gilles R., et al.
Publicado: (2020)

Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States
por: Boye, Kristina S., et al.
Publicado: (2019)

Generalizability of the Results of Cardiovascular Outcome Trials of Glucagon-Like Peptide 1 Receptor Agonists in Chinese Patients with Type 2 Diabetes Mellitus
por: Cai, Xiaoling, et al.
Publicado: (2021)

Rewinding the waves: tracking underwater signals to their source
por: Kadri, Usama, et al.
Publicado: (2017)

Mistreatment in Residency: Intervening With the REWIND Communication Tool
por: Pang, Joyce, et al.
Publicado: (2022)

Levorphanol: Rewinding an Old, Bygone Multimodal Opioid Analgesic!
por: Nair, Abhijit S, et al.
Publicado: (2019)

The reconsolidation using rewind study (RETURN): trial protocol
por: Astill Wright, Laurence, et al.
Publicado: (2021)

Cardiovascular Profile of Patients with Type 2 Diabetes in France Based on REWIND CVOT Inclusion Criteria: A Real-World Retrospective Study
por: Dib, Anne, et al.
Publicado: (2022)

Prevalence and treatment patterns of adult atopic dermatitis in the UK Clinical Practice Research Datalink
por: Kleyn, C. Elise, et al.
Publicado: (2023)

27 September 2013: Fast forward and rewind to our Origins
por: Antonella Del Rosso
Publicado: (2013)

OR30-06 Assessment of Dulaglutide Safety in Older Patient Populations in Rewind
por: Konig, Manige, et al.
Publicado: (2020)

Influence of the Strap Rewind Height During a Conical Pulley Exercise
por: Sabido, Rafael, et al.
Publicado: (2020)

Homecoming: rewinding the reductive evolution of the chloroplast genome for increasing crop yields
por: Llorente, Briardo, et al.
Publicado: (2021)

Retail Price and Point of Sale Display of Tobacco in the UK: A Descriptive Study of Small Retailers
por: Spanopoulos, Dionysis, et al.
Publicado: (2012)

Temporal variation of renal function in people with type 2 diabetes mellitus: A retrospective UK clinical practice research datalink cohort study
por: Spanopoulos, Dionysis, et al.
Publicado: (2019)

Rash, disseminated intravascular coagulation and legionella: Episode 10 and a rewind into the past
por: Thalanayar, Prashanth M., et al.
Publicado: (2015)

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study
por: Torre, Enrico, et al.
Publicado: (2020)

Rewinding the Molecular Clock: Looking at Pioneering Molecular Phylogenetics Experiments in the Light of Proteomics
por: Neely, Benjamin A., et al.
Publicado: (2021)

Direct cardiovascular effects of glucagon like peptide-1
por: Sheikh, Asfandyar
Publicado: (2013)

Tobacco display and brand communication at the point of sale: implications for adolescent smoking behaviour
por: Spanopoulos, Dionysis, et al.
Publicado: (2014)

Exposure to point‐of‐sale displays and changes in susceptibility to smoking: findings from a cohort study of school students
por: Bogdanovica, Ilze, et al.
Publicado: (2015)

General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial
por: Franek, Edward, et al.
Publicado: (2023)

The role of environmental factors and the generalizability of intergenerational differences in cardiovascular health among South Asian Americans
por: Patel, Devanshi P., et al.
Publicado: (2022)

Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial
por: Riddle, Matthew C, et al.
Publicado: (2021)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
por: Kang, Yu Mi, et al.
Publicado: (2016)

Sodium–glucose co‐transporter‐2 inhibitor cardiovascular outcome trials and generalizability to English primary care
por: Hinton, W., et al.
Publicado: (2020)

Generalizability of Cardiovascular Disease Clinical Prediction Models: 158 Independent External Validations of 104 Unique Models
por: Gulati, Gaurav, et al.
Publicado: (2022)

LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ
por: Rutten, Guy E. H. M., et al.
Publicado: (2016)

Burden of Moderate to Severe Atopic Dermatitis in Adults from France, Italy, and the UK: Patient-Reported Outcomes and Treatment Patterns
por: Kleyn, C. Elise, et al.
Publicado: (2022)

Generalizability theory
por: Brennan, Robert L
Publicado: (2001)

Concerns on Generalizability
por: Lin, Yongjian
Publicado: (2023)

Formation of supramolecular channels by reversible unwinding-rewinding of bis(indole) double helix via ion coordination
por: Mondal, Debashis, et al.
Publicado: (2022)

The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials
por: Leiter, Lawrence A., et al.
Publicado: (2020)

Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
por: Saraiva, Francisco Kerr, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b22rnq6pno026i7mpeqrnqjp4i